Evidence map›Paper›PMID 39045146›Full record

ArticleCurrent developments in nutrition2024

Effects of d-alanine Intake on Amino Acid Metabolism and Kidney Function in Healthy Adults: A Multicenter, Randomized Pilot Study.

Megumi Oshima, Tadashi Toyama, Tatsuhiko Toyama, Yusuke Nakade, Toshiaki Tokumaru, Keisuke Sako, Sho Kajikawa, Daiki Hayashi, Hajime Sanada, Takahiro Yuasa and 17 more

Abstract read
In one paragraph

Article in Current developments in nutrition, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Megumi OshimaDepartment of Nephrology and Rheumatology, Kanazawa University, Kanazawa, Japan.
Tadashi ToyamaDepartment of Nephrology and Rheumatology, Kanazawa University, Kanazawa, Japan.
Tatsuhiko ToyamaKouryo Clinic, Takaoka, Japan.
Yusuke NakadeDepartment of Clinical Laboratory, Kanazawa University, Kanazawa, Japan.
Toshiaki TokumaruDepartment of Nutrition, Kanazawa University Hospital, Kanazawa, Japan.
Keisuke SakoDepartment of Nephrology and Rheumatology, Kanazawa University, Kanazawa, Japan.
Sho KajikawaDepartment of Nephrology and Rheumatology, Kanazawa University, Kanazawa, Japan.
Daiki HayashiDepartment of Nephrology and Rheumatology, Kanazawa University, Kanazawa, Japan.
Hajime SanadaDepartment of Nephrology and Rheumatology, Kanazawa University, Kanazawa, Japan.
Takahiro YuasaDepartment of Nephrology and Rheumatology, Kanazawa University, Kanazawa, Japan.
Akihiko KoshinoDepartment of Nephrology and Rheumatology, Kanazawa University, Kanazawa, Japan.
Keisuke HorikoshiDepartment of Nephrology and Rheumatology, Kanazawa University, Kanazawa, Japan.
Taichiro MinamiDepartment of Nephrology and Rheumatology, Kanazawa University, Kanazawa, Japan.
Shunsuke TsugeDepartment of Nephrology and Rheumatology, Kanazawa University, Kanazawa, Japan.
Akira TamaiDepartment of Nephrology and Rheumatology, Kanazawa University, Kanazawa, Japan.
Shiori NakagawaDepartment of Nephrology and Rheumatology, Kanazawa University, Kanazawa, Japan.
Ryo NishiokaDepartment of Nephrology and Rheumatology, Kanazawa University, Kanazawa, Japan.
Takeshi ZoshimaDepartment of Nephrology and Rheumatology, Kanazawa University, Kanazawa, Japan.
Kiyoaki ItoDepartment of Nephrology and Rheumatology, Kanazawa University, Kanazawa, Japan.
Shinji KitajimaDepartment of Nephrology and Rheumatology, Kanazawa University, Kanazawa, Japan.
Ichiro MizushimaDepartment of Nephrology and Rheumatology, Kanazawa University, Kanazawa, Japan.
Akinori HaraDepartment of Nephrology and Rheumatology, Kanazawa University, Kanazawa, Japan.
Norihiko SakaiDepartment of Nephrology and Rheumatology, Kanazawa University, Kanazawa, Japan.
Miho ShimizuDepartment of Nephrology and Rheumatology, Kanazawa University, Kanazawa, Japan.
Masashi MitaKAGAMI INC., Osaka, Japan.
Yasunori IwataDepartment of Nephrology and Rheumatology, Kanazawa University, Kanazawa, Japan.
Takashi WadaDepartment of Nephrology and Rheumatology, Kanazawa University, Kanazawa, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: d-alanine administration prevented kidney damage in a murine acute kidney injury model. Further data are needed on the influence of d-alanine on kidney function in humans. Objective: This study investigated the effects of d-alanine intake on amino acid metabolism and kidney function in healthy volunteers. Methods: This multicenter pilot study randomly assigned individuals from the general Japanese population to receive 3 g or 6 g of d-alanine intake per day for 7 d in a 1:1 ratio. The primary endpoint was the mean change in plasma and urine d-alanine levels from baseline to 7 d after intake. The secondary endpoints were mean changes in kidney function and other clinical factors. Safety was assessed by evaluating adverse events and clinical parameters. Results: We randomly assigned 24 participants to the 3-g ( Conclusions: d-alanine intake increased plasma and urine d-alanine levels and was well tolerated in participants with normal kidney function. These results will be useful in future trials investigating the effects of d-alanine intake on kidney disease progression in patients with chronic kidney disease.This trial was registered at the UMIN Clinical Trials Registry as UMIN000051466.

Indexed as

amino acidchronic kidney diseased-alaninehealthy volunteersprospective study

Identifiers

PMID39045146
PMCPMC11262164

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.